Cointime

Cadence Neuroscience

company

About

Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.

  • Redmond,Washington,United States
  • 11 - 50

Highlights

Total Funding Amount
$15M
Funding Rounds
2
Investors
3
Employee Profiles
5

Details

Last Funding Type
Grant
Industries
Health Care,Neuroscience,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Cadence Neuroscience Inc.

Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with a procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols.

Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$15M
Cadence Neuroscience has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Oct 11, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 11, 2019 Grant — 1 Epilepsy — Detail
Oct 11, 2019 Series A $15M 2 Jazz Venture Partners — Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Cadence Neuroscience is funded by 3 investors. Epilepsy and Jazz Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Epilepsy Yes Grant
Jazz Venture Partners Yes Series A
Mayo Clinic Ventures — Series A

Employee Profiles

Number of Employee Profiles
5
Cadence Neuroscience has 5 current employee profiles, including Board member Gerry Brunk, MBA
Gerry Brunk, MBA
Board member
John F. Harris
Board member
Doug Sheffield
Executive
Kent Leyde
Executive
Kevin Chu
Board member
Cointime
เนื้อหา
บริษัท